cGxP.wire https://validator.w3.org/feed/docs/rss2.html Sironax Reaches 50% Enrollment in SIR4156 Obesity Trial Entera Bio Reports Stronger EB613 Bone-Building Effects Prelude and Lilly Partner to Test PRT13722 in Breast Cancer Bristol Myers Squibb Reports Positive RYZ101 Phase 3 Results TG Therapeutics Reports Five-Year BRIUMVI Comparison in MS Fujifilm Launches Synapse Pathology v3.0 With Expanded AI Stoke Therapeutics Presents STK-002 Data for Inherited Vision Loss Amphista Therapeutics Doses First Patient in AMX-883 Phase 1 Trial Tortugas Neuroscience Reports Positive Phase 2b Schizophrenia Results Savara to Present New Molgramostim Data at CHEST 2026 Galderma Reports New Research on Menopausal Skin Changes Mursla Bio Validates Tissue-Specific Liquid Biopsy Platform CervoMed Reports Positive NfL Biomarker Results With Neflamapimod Calluna Pharma Completes CAL101 Phase 2 IPF Trial Dosing Bristol Myers Squibb Reports Positive Phase 3 IPF Results Merck Reports One-Year Results for Remigromig in DME Racura Oncology Advances RC220 to 100 mg/m² in Lung Cancer Spiro Medical Treats First Asthma Patient in PULSAR Trial REGENXBIO Highlights Surabgene Lomparvovec in New Event Gates Wellcome Leap Commit $100M to Uzima Stillbirth Program Keenova Shares New TERLIVAZ HRS-AKI Analysis at ACG Meeting! Bausch Health Improves Cirrhosis Care With New Pathway AstraZeneca Reports HICKORY Trial Results for HPP Drug Zydus Therapeutics Reports Saroglitazar PBC Trial Analysis Blue Lake Biotechnology to Present BLB201 RSV Vaccine Data ArkBio Advances AK0406 in US Phase II Influenza Prevention Trial E2 Secures Dual FDA Clearances for HLO PE Thrombectomy System Castle Biosciences Shows TissueCypher Detects Barrett’s Risk Immorta Bio Advances AI-Designed Senolytic Immunotherapy Johnson & Johnson Reports TREMFYA Fistula Remission Data NervGen Doses First Participant in Phase 3 RESTORE Trial of NVG-291 ANI Pharmaceuticals Reports Positive ILUVIEN Phase 4 Trial Results First Tracks Reports Positive ANB033 Phase 1b Celiac Data BridgeBio Reports Real-World Acoramidis Benefits in ATTR-CM Cardurion Reports Phase 2 Tovinontrine Results in Heart Failure Claris Bio Reports Positive CSB-001 Data in LSCD Study BridgeBio Reports Encaleret Benefits in Phase 3 ADH1 Trial First Tracks Biotherapeutics to Report ANB033 Celiac Data Leads Biolabs Wins FDA Fast Track for Opamtistomig Idorsia Reports Aprocitentan Benefits in Obesity and CKM Sling Therapeutics Reports Durable Linsitinib Results in TED Trial Quince Rebrands as IRulya to Advance Pulmonary Drug Pipeline HCW Biologics Targets 2027 IND Filing for Solid Tumor Therapy Milestone Advances Etripamil Phase 3 Trial in Europe Teva Wins FDA Approval for Once-Monthly WELTRUZA Injection AnX Robotica Reports ProScan AI Workflow Performance Data Celltrion Reports New ZYMFENTRA Data in Crohn’s Disease AbbVie Reports New SKYRIZI and RINVOQ IBD Data Sebela Reports Phase 3 Tegoprazan Data for Reflux Disease Asahi Kasei Wins FDA Approval for HOVILPRI HSV Therapy